Previous Article | Next Article 
Journal of Clinical Microbiology, June 2001, p. 2348-2350, Vol. 39, No. 6
0095-1137/01/$04.00+0 DOI: 10.1128/JCM.39.6.2348-2350.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Antifungal Susceptibilities, Varieties, and Electrophoretic
Karyotypes of Clinical Isolates of Cryptococcus
neoformans from Brazil, Chile, and Venezuela
Belinda M.
Calvo,1
Arnaldo L.
Colombo,2
Olga
Fischman,2
A.
Santiago,3
L.
Thompson,4
Marcia
Lazera,5
Flavio
Telles,6
Kazutaka
Fukushima,7
Kazuko
Nishimura,7
Reiko
Tanaka,7
Makoto
Myiajy,7 and
M. Luiza
Moretti-Branchini8,*
Universidad del Zulia-Luz,
Maracaibo,1 and Hospital Clínico
de Caracas, Caracas,3 Venezuela;
Clínica Santa María, Santiago,
Chile4; Chiba University, Chiba,
Japan7; and Fundação Oswaldo
Cruz, Rio de Janeiro,5 Universidade
Federal de Paraná, Curitiba,6 and
Universidade Federal de São Paulo2
and Universidade Estadual de
Campinas,8 Campinas, Brazil
Received 10 July 2000/Returned for modification 28 August
2000/Accepted 8 April 2001
One hundred clinical isolates of Cryptococcus
neoformans from human immunodeficiency virus (HIV)-infected and
non-HIV-infected patients from Brazil, Chile, and Venezuela were
separated according to varieties and tested for antifungal
susceptibility. A high susceptibility to antifungal agents was observed
among all the isolates. The electrophoretic karyotyping of 51 strains
revealed good discrimination among Cryptococcus neoformans
var. neoformans strains.
*
Corresponding author. Mailing address: Infectious
Diseases Division, Faculdade de Ciências Médicas,
Universidade Estadual de Campinas (UNICAMP), Cidade Universitária
Zeferino Vaz, 13083-970, Campinas, São Paulo, Brazil. Phone:
55-19-3788-7734. Fax: 55-19-3236-2092. E-mail:
moretti{at}hc.unicamp.br.
Journal of Clinical Microbiology, June 2001, p. 2348-2350, Vol. 39, No. 6
0095-1137/01/$04.00+0 DOI: 10.1128/JCM.39.6.2348-2350.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Pfaller, M. A., Diekema, D. J., Gibbs, D. L., Newell, V. A., Bijie, H., Dzierzanowska, D., Klimko, N. N., Letscher-Bru, V., Lisalova, M., Muehlethaler, K., Rennison, C., Zaidi, M., the Global Antifungal Surveillance Group,
(2009). Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: 10.5-Year Analysis of Susceptibilities of Noncandidal Yeast Species to Fluconazole and Voriconazole Determined by CLSI Standardized Disk Diffusion Testing. J. Clin. Microbiol.
47: 117-123
[Abstract]
[Full Text]
-
Khan, Z. U., Randhawa, H. S., Kowshik, T., Chowdhary, A., Chandy, R.
(2007). Antifungal susceptibility of Cryptococcus neoformans and Cryptococcus gattii isolates from decayed wood of trunk hollows of Ficus religiosa and Syzygium cumini trees in north-western India. J Antimicrob Chemother
60: 312-316
[Abstract]
[Full Text]
-
Dannaoui, E., Abdul, M., Arpin, M., Michel-Nguyen, A., Piens, M. A., Favel, A., Lortholary, O., Dromer, F., the French Cryptococcosis Study Group,
(2006). Results obtained with various antifungal susceptibility testing methods do not predict early clinical outcome in patients with cryptococcosis.. Antimicrob. Agents Chemother.
50: 2464-2470
[Abstract]
[Full Text]
-
Jain, N., Wickes, B. L., Keller, S. M., Fu, J., Casadevall, A., Jain, P., Ragan, M. A., Banerjee, U., Fries, B. C.
(2005). Molecular Epidemiology of Clinical Cryptococcus neoformans Strains from India. J. Clin. Microbiol.
43: 5733-5742
[Abstract]
[Full Text]
-
Trilles, L., Fernandez-Torres, B., dos Santos Lazera, M., Wanke, B., Guarro, J.
(2004). In Vitro Antifungal Susceptibility of Cryptococcus gattii. J. Clin. Microbiol.
42: 4815-4817
[Abstract]
[Full Text]